Fewer patients in the resynchronization group required hospitalization (8% vs 15%) or intravenous medications (7% vs 15%).

• 接受心脏再同步治疗的患者，所需要的住院时间(8%25 比 15%25)或静脉内的给药量(7%25 比15%25)都减少了。